223 related articles for article (PubMed ID: 29347918)
1. Somatic evolutionary timings of driver mutations.
Gomez K; Miura S; Huuki LA; Spell BS; Townsend JP; Kumar S
BMC Cancer; 2018 Jan; 18(1):85. PubMed ID: 29347918
[TBL] [Abstract][Full Text] [Related]
2. Cancer heterogeneity: converting a limitation into a source of biologic information.
Rübben A; Araujo A
J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
[TBL] [Abstract][Full Text] [Related]
3. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
4. Order Matters: The Order of Somatic Mutations Influences Cancer Evolution.
Kent DG; Green AR
Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 28096247
[TBL] [Abstract][Full Text] [Related]
5. Deciphering intratumor heterogeneity using cancer genome analysis.
Ryu D; Joung JG; Kim NK; Kim KT; Park WY
Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
[TBL] [Abstract][Full Text] [Related]
6. SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing.
Niknafs N; Beleva-Guthrie V; Naiman DQ; Karchin R
PLoS Comput Biol; 2015 Oct; 11(10):e1004416. PubMed ID: 26436540
[TBL] [Abstract][Full Text] [Related]
7. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
[TBL] [Abstract][Full Text] [Related]
8. Cancer driver mutations: predictions and reality.
Ostroverkhova D; Przytycka TM; Panchenko AR
Trends Mol Med; 2023 Jul; 29(7):554-566. PubMed ID: 37076339
[TBL] [Abstract][Full Text] [Related]
9. The challenges of tumor genetic diversity.
Mroz EA; Rocco JW
Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
[TBL] [Abstract][Full Text] [Related]
10. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
11. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
[TBL] [Abstract][Full Text] [Related]
12. Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
Lawrence-Paul MR; Pan TC; Pant DK; Shih NNC; Chen Y; Belka GK; Feldman M; DeMichele A; Chodosh LA
Genome Med; 2024 Feb; 16(1):26. PubMed ID: 38321573
[TBL] [Abstract][Full Text] [Related]
13. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
14. Translating insights into tumor evolution to clinical practice: promises and challenges.
Fittall MW; Van Loo P
Genome Med; 2019 Mar; 11(1):20. PubMed ID: 30925887
[TBL] [Abstract][Full Text] [Related]
15. Tracking the Evolution of Non-Small-Cell Lung Cancer.
Jamal-Hanjani M; Wilson GA; McGranahan N; Birkbak NJ; Watkins TBK; Veeriah S; Shafi S; Johnson DH; Mitter R; Rosenthal R; Salm M; Horswell S; Escudero M; Matthews N; Rowan A; Chambers T; Moore DA; Turajlic S; Xu H; Lee SM; Forster MD; Ahmad T; Hiley CT; Abbosh C; Falzon M; Borg E; Marafioti T; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Shah R; Joseph L; Quinn AM; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Dentro S; Taniere P; O'Sullivan B; Lowe HL; Hartley JA; Iles N; Bell H; Ngai Y; Shaw JA; Herrero J; Szallasi Z; Schwarz RF; Stewart A; Quezada SA; Le Quesne J; Van Loo P; Dive C; Hackshaw A; Swanton C;
N Engl J Med; 2017 Jun; 376(22):2109-2121. PubMed ID: 28445112
[TBL] [Abstract][Full Text] [Related]
16. Biological background of the genomic variations of cf-DNA in healthy individuals.
Liu J; Chen X; Wang J; Zhou S; Wang CL; Ye MZ; Wang XY; Song Y; Wang YQ; Zhang LT; Wu RH; Yang HM; Zhu SD; Zhou MZ; Zhang XC; Zhu HM; Qian ZY
Ann Oncol; 2019 Mar; 30(3):464-470. PubMed ID: 30475948
[TBL] [Abstract][Full Text] [Related]
17. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.
McGranahan N; Favero F; de Bruin EC; Birkbak NJ; Szallasi Z; Swanton C
Sci Transl Med; 2015 Apr; 7(283):283ra54. PubMed ID: 25877892
[TBL] [Abstract][Full Text] [Related]
18. Mutational Heterogeneity in
Gausachs M; Borras E; Chang K; Gonzalez S; Azuara D; Delgado Amador A; Lopez-Doriga A; San Lucas FA; Sanjuan X; Paules MJ; Taggart MW; Davies GE; Ehli EA; Fowler J; Moreno V; Pineda M; You YN; Lynch PM; Lazaro C; Navin NE; Scheet PA; Hawk ET; Capella G; Vilar E
Clin Cancer Res; 2017 Oct; 23(19):5936-5947. PubMed ID: 28645942
[No Abstract] [Full Text] [Related]
19. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
Yang M; Topaloglu U; Petty WJ; Pagni M; Foley KL; Grant SC; Robinson M; Bitting RL; Thomas A; Alistar AT; Desnoyers RJ; Goodman M; Albright C; Porosnicu M; Vatca M; Qasem SA; DeYoung B; Kytola V; Nykter M; Chen K; Levine EA; Staren ED; D'Agostino RB; Petro RM; Blackstock W; Powell BL; Abraham E; Pasche B; Zhang W
J Hematol Oncol; 2017 May; 10(1):100. PubMed ID: 28472989
[TBL] [Abstract][Full Text] [Related]
20. Clonal evolution driven by superdriver mutations.
Grossmann P; Cristea S; Beerenwinkel N
BMC Evol Biol; 2020 Jul; 20(1):89. PubMed ID: 32689942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
